Skip to main content

Profile: Anne Gonzales-Luna

gonzales-luna-anne.jpg
Anne Gonzales-Luna, Pharm.D., BCIDP
Research Assistant Professor

Health 2
University of Houston College of Pharmacy
4849 Calhoun Road, Room 4033
Houston, TX 77204-5047

Education and Training

Post-Doctoral Fellowship – Infectious Diseases,The University of Houston College of Pharmacy

PGY-1 Pharmacy Practice Residency, Michael E. DeBakey Veterans Affairs Medical Center (MEDVAMC)

Doctor of Pharmacy, with Honors, The University of Texas at Austin College of Pharmacy

B.A. in Biology, with Honors, The University of Texas at Austin

Business Foundations Program Certificate, with High Distinction, The University of Texas at Austin

Certifications

  • Board of Pharmacy Specialties (BPS) Infectious Diseases Pharmacist
  • Teaching Certification, University of Houston College of Pharmacy
  • American Heart Association Advanced Cardiac Life Support (ACLS)
  • American Heart Association Basic Life Support (BLS) for Healthcare Providers
  • American Pharmacists Association (APhA) Medication Therapy Management,
  • Intravenous Sterile Products and Admixture Certification
  • APhA Pharmacy-Based Immunization Delivery
  • PCCA Introductory Compounding Lab Boot Camp (16 hours)

Publications

Carlson TJ, Endres BT, Pham JL, Gonzales-Luna AJ, Alnezary FS, Nebo K, Miranda J, Lancaster C, Bassères E, Begum K, Alam MJ, Reveles KR, Garey KW. Eosinopenia and binary toxin increases mortality in hospitalized patients with Clostridioides difficile infection. Open Forum Infect Dis. 2020; ofz552

Carlson TJ, Blasingame D, Gonzales-Luna AJ, Alnezary F, Garey KW. Clostridioides difficile ribotype 106: a systematic review of the antimicrobial susceptibility, genetics, and clinical outcomes of this common worldwide strain. Anaerobe. 2020; [Epub ahead of print]

Spinler JK, Gonzales-Luna AJ, Raza S, Runge JK, Luna RA, Savidge TC, Garey KW. Complete genome sequence of Clostridioides difficile ribotype 255 strain Mta-79, assembled using Oxford Nanopore and Illumina sequencing. Microbiol Resour Announc. 2019; 8(42):e00935-19

Lin Q, Pollock NR, Banz A, Lantz A, Xu H, Gu L, Gerding DN, Garey KW, Gonzales-Luna AJ, Zhao M, Song L, Duffy DC, Kelly CP, Chen X. Toxin A-predominant Pathogenic C. difficile: A Novel Clinical Phenotype. Clin Infect Dis. 2019 Aug 11. pii: ciz727. doi: 10.1093/cid/ciz727. [Epub ahead of print]

Borjan J, Gonzales-Luna AJ, Carlson TJ, Finch NA, Mitchell AP, McDaneld PM, Phe K, Foolad F. Significant Publications on Infectious Diseases Pharmacotherapy in 2018. J Pharm Pract. 2019; 32(5):546-57.

Gonzales-Luna A, Carlson TJ. Letter to the Editor. Clin Infect Dis. 2020; 70(2):355-6.

Carlson TJ, Endres BT, Basseres E, Gonzales-Luna AJ, Garey KW. Ridinilazole for the treatment of C. difficile infection. Expert Opin Invest Drugs. 2019; 28(4):303-10.

Endres BT, Begum K, Sun H, Walk ST, Memariani A, Lancaster C, Gonzales-Luna AJ, Dotson KM, Bassères K, Offiong C, Tupy S, Kuper K, Septimus E, Arafat R, Alam MJ, Zhao Z, Hurdle JH, Savidge TC, Garey, KW. Early emergence of epidemic Clostridioides difficile ribotype 027 lineages in the US: implications for fluoroquinolone use. Open Forum Infect Dis. 2019; 6(2):ofz013

Reveles KR, Dotson KM, Gonzales-Luna A, Surati D, Endres BT, Alam MJ, Garey KW. Clostridioides (formerly Clostridium) difficile infection during hospitalization increases the likelihood of non-home patient discharge. Clin Infect Dis. 2018; 68(11):1887-93.

Aitken S, Tarrand J, Deshpande L, Tverdek F, Jones A, Shelburne S, Prince R, Bhatti M, Rolston K, Jones R, Castanheira M, Chemaly R. High Rates of Nonsusceptibility to Ceftazidime-avibactam and Identification of New Delhi Metallo-ß-lactamase Production in Enterobacteriaceae Bloodstream Infections at a Major Cancer Center. Clin Infect Dis. 2016; 63(7):954-8.x

Posters and Abstracts

Blasingame D, Carlson TJ, Gonzales-Luna AJ, Alnezary F, Garey KW. Clostridioides difficile ribotype 106: a systematic review of the susceptibility, genetics, and clinical outcomes of this common worldwide strain. Poster #7-309. ASHP Midyear Annual Meeting. Las Vegas, Nevada. December 8-12, 2019.

Khan M, Ali MA, Carlson TJ, Gonzales-Luna AJ, Garey KW. Treatment of infections caused by carbapenem-resistant Enterobacteriaceae in a large academic medical center. Poster #7-326. ASHP Midyear Annual Meeting. Las Vegas, Nevada. December 8-12, 2019.

Kim C, Patel P, Carlson TJ, Gonzales-Luna AJ, Garey KW. Impact of acute and chronic glucocorticosteroid use on Clostridioides difficile infection-induced leukocytosis. Poster #7-306. ASHP Midyear Annual Meeting. Las Vegas, Nevada. December 8-12, 2019.

Dotson KM, Gonzales-Luna AJ, McPherson J, Lancaster C, Endres BT, Zasowski E, Begum K, Alam MJ, Garey KW. Increased Risk of Systemic Infections with Multidrug-Resistant Organisms in Patients with Severe Clostridioides difficile Infection. P2391. IDWeek 2019, Washington, D.C. October 2-6, 2019.

Gonzales-Luna AJ, Lancaster C, Khan MAW, Begum K, Endres BT, Rashid T, Carlson TJ, Alam MJ, Garey KW. Serial Microbiome Analysis in a Patient with Multiple Failed Fecal Microbiome Transplantations. P2580. IDWeek 2019, Washington, D.C. October 2-6, 2019.

Gonzales-Luna AJ, Carlson TJ, Lancaster C, Miranda J, Garey KW. Clinical Outcomes Associated with an Emerging Clostridioides difficile Ribotype 255 in Texas. P2402. IDWeek 2019, Washington, D.C. October 2-6, 2019.

Carlson TJ, Endres BT, Pham JL, Gonzales-Luna AJ, Alnezary FS, Nebo K, Miranda J, Begum K, Alam MJ, Garey KW. Effect of eosinopenia and binary toxin on Clostridioides difficile infection clinical outcomes. P2398. IDWeek 2019, Washington, D.C. October 2-6, 2019.

Carlson TJ, Wilcox MF, Theriault SG, Alnezary FS, Gonzales-Luna AJ, Zasowski EJ, Garey KW. Corticosteroid use prevents primary Clostridioides difficile infection in the setting of broad-spectrum antibiotic use among hospitalized patients. P2378. IDWeek 2019, Washington, D.C. October 2-6, 2019.

Alnezary FS, Rashid T, Ijeoma MO, Carlson TJ, Gonzales-Luna AJ, Alam MJ, Garey KW. A novel invertebrate model to study effect of antibiotics on the gut microbiome using Galleria mellonella. P2581. IDWeek 2019, Washington, D.C. October 2-6, 2019.

Bassères E, Miranda J, Gonzales-Luna AJ, Carlson TJ, Rashid T, Alam MJ, Garey KW. In vitro activity of eravacycline, a new tetracycline analog, and comparators against the six most commonly isolated ribotypes of Clostridioides difficile. P688. IDWeek 2019, Washington, D.C. October 2-6, 2019.

Gonzales-Luna AJ, Carlson TJ, Dotson KM, Lancaster C, Miranda J, Endres BT, Bassères E, Begum K, Alam MJ, Garey KW. Texas statewide surveillance of Clostridioides difficile infection, 2011-2018. P0275. 29th ECCMID, Amsterdam, Netherlands. April 13-16, 2019.

Carlson TJ, Gonzales-Luna AJ, Endres BT, Lancaster C, Miranda J, Bassères E, Begum K, Alam MJ, Garey KW. Epidemiologic surveillance of carbapenem-resistant Enterobacteriaceae in a large academic teaching hospital in Houston, Texas. 2nd Annual Texas Medical Center Antimicrobial Resistance Research and Stewardship Conference. Houston, Texas. January 23-25, 2019.

Endres BT, Begum K, Gonzales-Luna AJ, Carlson TJ, Alam MJ, Garey KW. Using genomics to identify hospital-based antimicrobial resistance patterns among Clostridioides difficile. Poster #3-315. ASHP Midyear Annual Meeting. Anaheim, California. December 2-6, 2018.

Gonzales-Luna AJ, Shen WJ, Dotson KM, Lancaster C, Endres BT, Hossain F, Begum K, Cernoch P, Perez KK, Tisdel N, Barrett M, Muldrew KL, Alam MJ, Garey KW, Hurdle. J. Increased Clinical Failure Rates Associated with Reduced Metronidazole Susceptibility in Clostridioides difficile. P710. IDWeek 2018, San Francisco, California. October 3-7, 2018. doi: 10.1093/ofid/ofy210.717

Gonzales-Luna AJ, Perez KK, Gentry CN. Candidemia Guideline Adherence: Impacts of Echinocandin Treatment Compliance and Antimicrobial Stewardship on Outcomes at a Large Hospital System Antibiotics for Common Outpatient Conditions. 1st Annual Texas Medical Center Antimicrobial Resistance and Stewardship Conference, Houston, Texas. January 18-19, 2018.

Gonzales-Luna AJ, Musher DM, Cadle RM, Hunter A. Rates of Clostridium difficile infections associated with the frequency-adjusted use of antibiotic agents in an academic Veterans Affairs Medical Center. Poster #1-351. ASHP Midyear Annual Meeting, Las Vegas, Nevada. December 4-8, 2016.

Aitken SL, Marx K, Tverdek F, Taremi M, Jones A, Chemaly RF, Mulanovich V, Shelburne S, Rolston KVI. Impact of an antibiotic checklist on broad-spectrum Gram-positive antibiotic use in leukaemia patients. P1211. 26th ECCMID, Amsterdam, Netherlands. April 9-12, 2016.

Presentations

Prevention and Treatment of Recurrent Clostridioides difficile Infection: A Call to Action ASHP Midyear Annual Meeting 2019, Las Vegas, NV

Clinical Failure Rates Associated with Hemin-induced Metronidazole Resistance in Clostridioides difficile IDWeek 2019, Washington, D.C.

Continuing the Story: Outcomes Associated with Heme-induced Metronidazole Resistance in Clostridioides difficile Fellowship Forum Meeting, Providence, RI

Increased Clinical Failure Rates Associated with Reduced Metronidazole Susceptibility in Clostridioides difficile Fellowship Forum Meeting, Buffalo, NY

Candidemia Guideline Compliance Houston Methodist Hospital, TMC Antimicrobial Stewardship Committee Houston Methodist Hospital System-wide ASP Committee, Houston TX

Memberships

  • European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Spring 2019 – present
  • Infectious Diseases Society of America (IDSA), Fall 2017 – present
  • Society of Infectious Disease Pharmacists (SIDP), Fall 2017 – present
  • American College of Clinical Pharmacy (ACCP), Fall 2017 – present
  • Gulf Coast Society of Health-System Pharmacists (GCSHP), Fall 2015 – present
  • Texas Pharmacy Association (TPA), Fall 2012 – present
  • American Society of Health-System Pharmacists (ASHP), Fall 2012 – present
  • Texas Society of Health-System Pharmacists (TSHP), Fall 2012 – present

Honors and Awards

  • Phi Beta Kappa society
  • Best UT College of Pharmacy Student Presentation – Houston Region
  • Best Student Community Service Project
  • Alpha Lambda Delta national honor society
  • Phi Eta Sigma national honor society